JAK2/ULK1轴通过自诱导和SRPK1酸化促进子宫癌的进展
Qiuhong Duan1,2,3, Wei Wang4, Hua Xiong5
1Translational Medical Center, Huaihe Hospital, Henan University, Kaifeng, Henan, 475000, PR China. duanqhwz@henu.edu.cn.
这项研究揭示了JAK2在Tyr1007中酸化ULK1,增强其活性并通过自性促进宫癌 (CCa) 的进展. 这种酸化作为CCa患者结果的新型预测标记.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 子宫癌 (CCa) 是一种流行的妇科恶性瘤.
- 自在CCa进展中发挥着作用.
- ULK1是启动自的关键激酶,但其在CCa中的氨酸酸化尚未研究.
研究的目的:
- 调查ULK1氨酸酸化在CCa进展中的作用.
- 为了识别上游激酶和下游点,涉及到这个途径.
- 探索ULK1酸化作为CCa.的预后标记物的潜力.
主要方法:
- 研究了JAK2和ULK1.1之间的相互作用.
- 评估了Tyr1007中ULK1酸化对其活性和稳定性的影响.
- 分析了这种酸化对自和CCa细胞增殖的影响.
- 在CCa中确定ULK1的下游目标.
- 与患者结局相关的ULK1酸化水平.
主要成果:
- 在Tyr1007.7.中,JAK2被确定为一种新的上游激酶,在Tyr1007.1酸化ULK1.
- 在Y1007的ULK1酸化增强了它的活性和稳定性,促进了自和CCa的进展.
- 在Y1007中ULK1的酸化是CCa患者预后的预测标记.
- 在CCa进展中,SRPK1被确定为ULK1的潜在下游基质.
结论:
- JAK2/ULK1信号轴对于CCa进展至关重要.
- 在Tyr1007中ULK1酸化是一个重要的分子机制,驱动CCa.
- ULK1 Tyr1007酸化代表了宫癌的一个有前途的预测生物标志物.
更多相关视频
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Anaphase Promoting Complex
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
